StockNews.com upgraded shares of Jaguar Health (NASDAQ:JAGX – Free Report) from a sell rating to a hold rating in a research note issued to investors on Tuesday morning.
Jaguar Health Stock Performance
NASDAQ JAGX opened at $1.16 on Tuesday. The firm’s 50 day simple moving average is $3.45 and its 200 day simple moving average is $6.14. The company has a current ratio of 1.89, a quick ratio of 1.39 and a debt-to-equity ratio of 1.84. Jaguar Health has a 1 year low of $1.11 and a 1 year high of $37.50.
Jaguar Health (NASDAQ:JAGX – Get Free Report) last issued its earnings results on Tuesday, May 14th. The biotechnology company reported ($3.60) earnings per share for the quarter. The business had revenue of $2.35 million during the quarter. Jaguar Health had a negative net margin of 377.95% and a negative return on equity of 642.15%. On average, equities analysts expect that Jaguar Health will post -0.69 earnings per share for the current fiscal year.
About Jaguar Health
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.
See Also
- Five stocks we like better than Jaguar Health
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Should You Invest in Bitcoin? Pros and Cons
- P/E Ratio Calculation: How to Assess Stocks
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- Stock Market Upgrades: What Are They?
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.